No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Prandin (repaglinide) is a medication used to treat type 2 diabetes. It belongs to a class of drugs known as Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Prandin works by stimulating the pancreas to produce more insulin, which helps the body to better process glucose. Prandin is typically prescribed in combination with diet and exercise to help control blood sugar levels.
Prandin is marketed by Novo Nordisk, a global healthcare company that specializes in diabetes care. Other companies that produce Endocrine and Metabolic Disorders Drugs include Sanofi, Eli Lilly, and Merck. Show Less Read more
